HOME >> MEDICINE >> NEWS
Are some medicines so good they should be free? In diabetes, the answer may be yes

ho has never had a stroke.

"In our society, we often pay for health strategies that provide health benefits at a reasonable but added cost," says Rosen. "But this strategy goes even further: it saves lives and saves money. Removing patient financial barriers for ACE inhibitors prevents expensive and life-threatening complications, and improves quality of life. In so doing, patients pay less, Medicare pays less, and everyone wins. It's a virtual no-brainer."

Even if the availability of free ACE inhibitors didn't cause a major upswing in the use of the drugs by these patients, the strategy would still pay for itself, Rosen says.

"If only 7 percent more people started taking ACE inhibitors when they were offered at no cost, Medicare would still save money. The more people that take advantage of the no-cost drugs, the bigger the savings for Medicare over the long term. And of course, each patient has a lower risk of heart attack, stroke, or kidney failure."

The researchers ran the computer model many times, making changes each time in 38 different variables. Ninety percent of the time, they found that no-cost ACE inhibitors saved money; the other 10 percent of the time they were cost-effective -- costing less than $20,000 per QALY gained.

The authors also looked at costs and savings on a societal, rather than Medicare, level -- including patients' productivity and the cost of caregiving for people with health-related disability. The savings were even greater than Medicare savings alone.

If Medicare were able to purchase ACE inhibitors for all its diabetes patients at the same low cost that the Department of Defense pays, the government's lifetime savings on each patient would be even higher. And it would only take a 1.1 percent increase in patient use of ACE inhibitors to make the program cost-saving.

Rosen notes that the analysis doesn't even take into account more recent evidence that ACE inhibitors can also
'"/>

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System
18-Jul-2005


Page: 1 2 3 4 5

Related medicine news :

1. New drug development facility helps move medicines to market
2. To get blood pressure under control, combination of medicines may be best
3. Italian doctors get their information on medicines from drug company sales reps
4. Most children in US hospitals receive medicines off-label
5. Study finds differences between blood pressure medicines and newly-diagnosed diabetes
6. Liverpool launches 20 million project to develop medicines for children
7. National study compares delivery methods of schizophrenia medicines
8. More than half of older diabetics lack medicines that protect kidneys and heart
9. Conference calls for global approach to risk management in medicines, food, environment
10. UQ research will move medicines to market more quickly
11. Racial disparities in access to medicines increase after implementation of prescription surveillance

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Are some medicines good they should free diabetes the answer may yes

(Date:7/28/2015)... ... ... Morristown Medical Center, part of Atlantic Health System, today announced it was ... the nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. The ... condition. , The CoreValve® Evolut® R System was approved by the U.S. Food and ...
(Date:7/28/2015)... Francisco, California (PRWEB) , ... July 28, 2015 , ... ... the results from a recent survey (1) examining consumers’ perspectives on digital ... June 17-24, 2015, covered topics such as innovations in digital health, level of trust ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Dr. Aziz Ahmad ... The talk took place from noon to 1 p.m. Tuesday, June 23, at the ... Fla. , Dr. Ahmad is board-certified in colorectal surgery and has more than ...
(Date:7/28/2015)... ... ... to Kxan on June 24th a previously FDA approved blood pressure medication ... isradipine has garnered national attention and is making drug and alcohol rehabilitation medical physicians ... The study was conducted by the University of Texas. Human trials may be set ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... Kinetic Data announced that Schneider Electric has completed its upgrade and expansion ... a global organization with more than 170,000 employees in 134 countries supplying a ...
Breaking Medicine News(10 mins):Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Dr. Aziz Ahmad Delivers Talk at Gulf Coast Medical Center 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 2Health News:Blood Pressure Medication May be the Key to Treating Addiction 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4
(Date:7/28/2015)... 2015  For many medical institutions and universities, commercializing ... inventors can be a constant challenge. Taking an idea ... are rare. A new company in ... Medical Device Investments (MDI) was created to commercialize ... physicians. MDI develops, manufactures and markets the products, with ...
(Date:7/28/2015)... , July 28, 2015   CSL ... for review a Marketing Authorization Application (MAA) for ... coagulation factor IX with recombinant albumin (rIX-FP) for ... people with Hemophilia B. Upon Swissmedic approval, rIX-FP ... treatment option with dosing intervals up to 14 ...
(Date:7/28/2015)... , July 28, 2015 VirtualScopics, Inc. (NASDAQ: ... imaging solutions, today announced that it will report its ... ET market close on Tuesday, August 11, 2015.  ... and Jim Groff , chief financial officer, will ... company,s financial results and provide a business update at ...
Breaking Medicine Technology:Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3
Cached News: